Fabrizio Tabbò (0000-0001-8525-2992) - ORCID

We notice you are using a browser that our site does not support. Some features on this site may not work correctly. We recommend that you upgrade to a supported browser.

Personal information

Activities

Collapse all

Clinical and Molecular Traits of a Novel SPECC1L-ALK Fusion in a Patient with Advanced Non-Small Cell Lung Cancer

Journal of Personalized Medicine

2024-06 | Journal article | Author

DOI: 10.3390/jpm14070670

Contributors: Antonella Centonza; Tommaso Mazza; Domenico Trombetta; Angelo Sparaneo; Francesco Petrizzelli; Stefano Castellana; Flavia Centra; Federico Pio Fabrizio; Concetta Martina Di Micco; Federica Benso et al.

Show more detail

Source:

check_circle

Multidisciplinary Digital Publishing Institute

Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations

Cancers

2021-05 | Journal article | Author

DOI: 10.3390/cancers13102425

Contributors: Paolo Bironzo; Maria Lucia Reale; Tessa Sperone; Fabrizio Tabbò; Andrea Caglio; Angela Listì; Francesco Passiglia; Massimo DI MAIO; Luisella Righi; Federico Bussolino et al.

Show more detail

Source:

check_circle

Multidisciplinary Digital Publishing Institute

Review activity for BMC cancer (3)

Review activity for Signal transduction and targeted therapy. (1)

How many people are using ORCID?